Clinical Trials Directory

Trials / Unknown

UnknownNCT02599311

the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery

The Clinical Efficacy of Pelvic Organ Prolapse Surgery

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
Female
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

One thousand patients with stage\>2 POP are recruited. The patients are all received surgeries,such as transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis. The patients with POP who have not undergone surgery are excluded. Postoperatively, the investigators investigate the indications and clinical efficacy of pelvic organ prolapse surgery.

Detailed description

Postoperatively, the investigators analyze the patients' subjective and objective recurrent rates. The investigators compare the quality of life by filling out the preoperative and postoperative scoring questionnaires (PISQ 12, PFDI-20, PFIQ-7).The electrical physiological changes will be focused on. The investigators also use Overactive Bladder Symptom Score(OABss) to assess the lower urinary tract symptoms.

Conditions

Interventions

TypeNameDescription
DEVICEtransvaginal synthetic meshtransvaginal synthetic mesh
DRUGTolterodineTolterodine tartrate can improve patients' LUTS.

Timeline

Start date
2015-08-01
Primary completion
2019-10-01
Completion
2020-10-01
First posted
2015-11-06
Last updated
2017-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02599311. Inclusion in this directory is not an endorsement.